Elsevier,
Field Measurements for Passive Environmental Remote Sensing: Instrumentation, Intensive Campaigns, and Satellite Applications, 2023, pp 79-100
This chapter aligns with Goal 14: Life Below Water and Goal 9: Industry, innovation and infrastructure by describing the advancements in scientific data collection capabilities afforded by the innovation and use of oceanographic buoys.
Elsevier,
Complementarity of Variable Renewable Energy Sources, 2022, pp 527-558
This chapter aligns with Goal 14: Life Below Water and Goal 13: Climate Action by exploring the potential of marine renewables, including wind, wave, and solar, for providing long-term sustainable energy sources.
Elsevier,
Not Just Bad Kids, The Adversity and Disruptive Behavior Link 2022, Pages 569-594
This chapter advances SDGs 3, 4, and 10 by exploring topics with emphasis on the benefits and challenges of talking with youth about race and identity, strategies for coping, and ways that we can help promote racial healing in ourselves and our communities.
Elsevier,
Handbook of Clinical Neurology
Volume 185, 2022, Pages 81-97
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing coverage of the clinical syndrome of a primary progressive aphasia (PPA), the demographics of this rare neurodegenerative disease, defining clinical and neuroanatomic characteristics of each PPA variant, disease progression, and behavioral features.
Clinical Ophthalmic Genetics and Genomics, 2022, Pages 457-463Gallie
Understanding the genetics of retinoblastoma has enabled clinicians to develop targeted screening guidelines based on genetic risk, minimising unnecessary screening exams, and focusing resources on individuals at greatest risk. The goal of SDG target 3.d is to strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risk.
Elsevier,
Clinical Ophthalmic Genetics and Genomics
2022, Pages 457-463
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing understaning of the genetics of retinoblastoma enabling clinicians to develop targeted screening guidelines based on genetic risk, minimising unnecessary screening exams, and focusing resources on individuals at greatest risk.
